Oppenheimer said QUALCOMM, Inc. (NASDAQ: QCOM)’s legal issues
won’t hurt its pending acquisition of NXP Semiconductors NV (NASDAQ: NXPI), which it had agreed to buy in October for $110.00 a share in cash,
representing a total enterprise value of about $47 billion.
The earnings call of Qualcomm, which reported an in-line EPS,
was focused heavily on its legal disputes with Apple Inc. (NASDAQ: AAPL), Korean FTC, EU, China and US FTC.
“We don't expect legal issues to impact the pending NXPI acquisition, and continue to expect the deal close by the end of CY17,”
analyst Rick Schafer wrote in a note.
However the analyst noted that the legal issues suggest that structural
headwinds continue for Qualcomm's technology licensing business (QTL), while its CDMA business (QCT) faces increased
competition.
Positive On Deal
This is where diversification comes in handy. NXP, a maker of mixed-signal semiconductor electronics, is expected to boost
Qualcomm’s footprint in automotive, Internet of Things, security and networking areas.
“We see the acquisition as 25+ percent accretive in CY18, assuming 50 percent of the $500 million synergy target,” Schafer
highlighted.
Despite being positive on the NXP deal, the analyst maintained his Perform rating on Qualcomm shares, citing headwinds in both
QCT and QTL segments.
Schafer pointed that first quarter MSM of 217 million was in line with consensus, but down 10 percent year-over-year due, in
part, to losing share to Intel Corporation (NASDAQ: INTC) in Apple's iPhone 7. Also, the MSM guidance of 175 million is a 7 percent
year-over-year drop.
Meanwhile, the analyst slashed his CY 2017 non-GAAP EPS estimate to $4.55 from $4.78 on higher tax rate and costs.
At last check, shares of Qualcomm were down 5.52 percent to $53.76.
Image Credit: By Ryo FUKAsawa (https://www.flickr.com/photos/fukapon/21879687510) [CC BY 2.0], via
Wikimedia Commons
Latest Ratings for NXPI
Date |
Firm |
Action |
From |
To |
Dec 2016 |
Citigroup |
Initiates Coverage On |
|
Neutral |
Nov 2016 |
Mizuho |
Downgrades |
Buy |
Neutral |
Nov 2016 |
Pacific Crest |
Downgrades |
Overweight |
Sector Weight |
View More Analyst Ratings for
NXPI
View the Latest Analyst Ratings
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.